1. Home
  2. GF vs STXS Comparison

GF vs STXS Comparison

Compare GF & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GF

New Germany Fund Inc. (The)

HOLD

Current Price

$10.26

Market Cap

184.9M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.88

Market Cap

201.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GF
STXS
Founded
1990
1990
Country
Germany
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.9M
201.6M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
GF
STXS
Price
$10.26
$1.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
20.2K
391.8K
Earning Date
01-01-0001
03-09-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$34.08
Revenue Next Year
N/A
$35.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.80
$1.54
52 Week High
$12.82
$3.59

Technical Indicators

Market Signals
Indicator
GF
STXS
Relative Strength Index (RSI) 29.69 42.13
Support Level N/A $1.74
Resistance Level $12.32 $2.52
Average True Range (ATR) 0.29 0.11
MACD -0.05 0.00
Stochastic Oscillator 3.64 30.20

Price Performance

Historical Comparison
GF
STXS

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: